Will new therapy for genetic disease alter underwriting practices?

J Insur Med. 1993:Suppl B:247-51.
No abstract available

MeSH terms

  • Animals
  • DNA, Recombinant / therapeutic use
  • Enzyme Therapy
  • Forecasting
  • Genetic Diseases, Inborn / drug therapy*
  • Genetic Therapy* / trends
  • Humans
  • Insurance, Health
  • Insurance, Life
  • Metabolic Diseases / drug therapy*
  • Metabolic Diseases / enzymology
  • Mice

Substances

  • DNA, Recombinant